Marshall Fordyce is CEO & President at Vera Therapeutics, Inc. (VERA). They have made 8 open-market trades across 1 company since 2022, most recently 2026-09-15.
CIK 0001859453
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VERA | 235,244 | $6.6M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VERA | SELL · 10b5-1 | 2026-09-15 | 2026-09-17 | $37.00 | $685K | -5.4% | — | — |
| VERA | SELL · 10b5-1 | 2026-09-02 | 2026-09-04 | $35.12 | $650K | -3.9% | -16.3% | — |
| VERA | SELL · 10b5-1 | 2026-07-07 | 2026-07-09 | $42.30 | $2.0M | -11.3% | -24.6% | -27.8% |
| VERA | SELL · 10b5-1 | 2026-06-23 | 2026-06-24 | $37.93 | $702K | +8.0% | -11.0% | -9.0% |
| VERA | SELL · 10b5-1 | 2026-05-12 | 2026-05-13 | $36.74 | $680K | -12.0% | -12.2% | -22.2% |
| VERA | SELL · 10b5-1 | 2026-04-14 | 2026-04-15 | $44.05 | $1.0M | -14.1% | -13.9% | -0.7% |
| VERA | SELL | 2026-02-23 | 2026-02-25 | $41.98 | $711K | -5.5% | -5.8% | -16.8% |
| VERA | SELL · 10b5-1 | 2025-02-21 | 2025-02-27 | $27.76 | $1.1M | -2.2% | -17.1% | -34.9% |
| VERA | SELL · 10b5-1 | 2025-01-08 | 2025-01-10 | $41.73 | $1.4M | -2.6% | +2.5% | -37.7% |
| VERA | SELL · 10b5-1 | 2024-12-18 | 2024-12-20 | $43.07 | $1.5M | +2.6% | -20.0% | -34.2% |
| VERA | SELL · 10b5-1 | 2024-12-11 | 2024-12-13 | $46.93 | $1.6M | -3.6% | -21.0% | -37.2% |
| VERA | SELL · 10b5-1 | 2024-11-25 | 2024-11-27 | $47.88 | $1.7M | -4.4% | -15.6% | -44.8% |
| VERA | SELL · 10b5-1 | 2024-11-13 | 2024-11-15 | $49.57 | $2.6M | +6.9% | -3.8% | -25.2% |
| VERA | SELL · 10b5-1 | 2024-10-23 | 2024-10-25 | $40.16 | $1.3M | -3.9% | -5.3% | -31.7% |
| VERA | SELL · 10b5-1 | 2024-10-09 | 2024-10-11 | $38.24 | $1.2M | -6.2% | +14.5% | -12.9% |
| VERA | SELL · 10b5-1 | 2024-09-25 | 2024-09-27 | $45.99 | $1.6M | -10.3% | +9.1% | -2.2% |
| VERA | SELL · 10b5-1 | 2024-09-11 | 2024-09-13 | $37.50 | $1.2M | +19.4% | +12.1% | +19.9% |
| VERA | SELL · 10b5-1 | 2024-08-28 | 2024-08-30 | $36.84 | $1.6M | -7.5% | +14.6% | +29.0% |
| VERA | SELL | 2024-08-21 | 2024-08-23 | $39.76 | $1.2M | -2.9% | +13.4% | +19.7% |
| VERA | SELL · 10b5-1 | 2024-08-14 | 2024-08-16 | $37.56 | $587K | -1.7% | +7.4% | +31.2% |
| VERA | SELL · 10b5-1 | 2023-08-21 | 2023-08-23 | $16.66 | $174K | +5.2% | -17.8% | -23.4% |
| VERA | SELL | 2022-10-03 | 2022-10-05 | $20.88 | $1.3M | -5.3% | -18.5% | -12.1% |
| VERA | SELL | 2022-09-13 | 2022-09-14 | $21.04 | $684K | -2.7% | -8.9% | -7.4% |
| VERA | SELL | 2022-09-09 | 2022-09-13 | $20.43 | $1.2M | +5.0% | -3.7% | -14.7% |
| VERA | SELL | 2022-09-07 | 2022-09-09 | $20.37 | $892K | +11.4% | +0.4% | -17.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.